Skip to search formSkip to main content
You are currently offline. Some features of the site may not work correctly.

Cisplatin Vindesine Protocol

Known as: PV protocol, VP regimen 
National Institutes of Health

Related topics

Related topics

1 relation
VDA-P protocol

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
2002
2002
A phase III randomized trial comparing vindesine and cisplatin with or without ifosfamide in patients with advanced non-small-cell lung cancer: long-term follow-up results and analysis of prognostic…
UNLABELLED In order to evaluate the activity and toxicity of a three-drug combination of vindesine, ifosfamide and cisplatin (VIP… Expand
1996
1996
Phase II study of alternating doses of vinorelbine in combination with cisplatin for non-small cell lung cancer (NSCLC): a disappointing experience.
UNLABELLED In both Phase III trials of vinorelbine-cisplatin (VP) versus single-agent vinorelbine, the received vinorelbine dose… Expand
1994
1994
Liver function studies in children with acute lymphocytic leukemia after cessation of therapy.
We investigated liver function in 27 children with acute lymphocytic leukemia (ALL) after cessation of therapy. Induction therapy… Expand
1994
1994
Drug delivery analysis of the Canadian multicenter trial in non-small-cell lung cancer.
PURPOSE The Canadian multicenter trial for advanced non-small-cell lung cancer (NSCLC) reported survival benefit for chemotherapy… Expand
By clicking accept or continuing to use the site, you agree to the terms outlined in our Privacy Policy, Terms of Service, and Dataset License
ACCEPT & CONTINUE